Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Receivables - Other (2024 - 2025)

Historic Receivables - Other for Gossamer Bio (GOSS) over the last 2 years, with Q3 2025 value amounting to $400000.0.

  • Gossamer Bio's Receivables - Other rose 30000.0% to $400000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $400000.0, marking a year-over-year increase of 30000.0%. This contributed to the annual value of $200000.0 for FY2024, which is N/A changed from last year.
  • Per Gossamer Bio's latest filing, its Receivables - Other stood at $400000.0 for Q3 2025, which was up 30000.0% from $400000.0 recorded in Q2 2025.
  • Gossamer Bio's Receivables - Other's 5-year high stood at $400000.0 during Q2 2025, with a 5-year trough of $100000.0 in Q3 2024.